SCHEMBL21982016

SCHEMBL21982016

CSc1cc(F)cc(Nc2cc(NC(C)(C)C)nc(-c3cccc(C(C)(F)F)n3)n2)c1

nearest known ligand 0.48

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ IDH1 O75874 19/20 0.48
▸ IDH2 P48735 3/20 0.41
▸ TGFBR1 P36897 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16391758 0.90 IDH1 (0.54) IDH1IDH2
SCHEMBL21977052 0.87 IDH1 (0.51) IDH1IDH2TGFBR1
SCHEMBL21982017 0.85 IDH1 (0.58) IDH1IDH2
SCHEMBL16392185 0.84 IDH1 (0.62) IDH1IDH2
SCHEMBL16392198 0.83 IDH1 (0.47) IDH1IDH2TGFBR1
SCHEMBL21981964 0.82 IDH1 (0.54) IDH1IDH2
SCHEMBL16391759 0.79 IDH1 (0.52) IDH1IDH2
SCHEMBL16391846 0.78 IDH1 (0.57) IDH1IDH2
SCHEMBL16391613 0.77 IDH1 (0.54) IDH1IDH2TGFBR1
SCHEMBL21977245 0.76 IDH1 (0.49) IDH1IDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3019480-B1 2,4- OR 4,6-DIAMINOPYRIMIDINE COMPOUNDS AS IDH2 MUTANTS INHIBITORS FOR THE TREATMENT OF CANCER AGIOS PHARMACEUTICALS INC (US) 2020-05-06 — — EP disclosed
Send feedback